BRTX
Biorestorative Therapies Inc. (BRTX)
NASDAQ · Healthcare
Biorestorative Therapies Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Biorestorative Therapies Inc. revenue for the quarter ending March 31, 2026 was 23170, a 7.32% decrease year-over-year.
- Biorestorative Therapies Inc. revenue for the twelve months ending March 31, 2026 was 363270, a 6.47% decrease year-over-year.
- Biorestorative Therapies Inc. annual revenue for 2025 was 359700, a 10.30% decrease from 2024.
- Biorestorative Therapies Inc. annual revenue for 2024 was 401000, a 175.03% increase from 2023.
- Biorestorative Therapies Inc. annual revenue for 2023 was 145800, a 21.70% increase from 2022.
- Biorestorative Therapies Inc. annual revenue for 2022 was 119800.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Biorestorative Therapies Inc. Earnings — FAQ
Biorestorative Therapies Inc. (BRTX) earnings over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BRTX's earnings history?
The chart and table above show Biorestorative Therapies Inc.'s earnings by year and by quarter, including the growth rate.